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Profiles of blood and blood component transfusion recipients in Zimbabwe
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Groningen, Groningen, The Netherlands; 2National Blood Service Zimbabwe, Harare, Zimbabwe; 3Department 
of Clinical Pharmacology, University of Zimbabwe, Harare, Zimbabwe; 4Liverpool School of Tropical Medicine, 
Liverpool, United Kingdom; 5Department of Orthopaedics, Makerere University, Kampala, Uganda; 6Institute of 
Science in Healthy Ageing & health caRE (SHARE), University Medical Centre Groningen (UMCG), Groningen; 
7Department of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands
Background. There are limited published data on the characteristics of blood transfusion recipients 
in sub-Saharan Africa. This study describes the demographic characteristics of blood transfusion 
recipients and patterns of blood and blood component use in Zimbabwe.
Materials and methods. Data on the characteristics of the blood transfusion recipients (age, 
sex, blood group), blood components received (type, quantity), discharge diagnoses and outcomes 
following transfusion (discharge status, duration of stay in hospital), were retrospectively collected 
from four major hospitals for the period from January 1, 2012 to December 31, 2012. Diagnoses were 
grouped into broad categories according to the disease headings of the International Classification 
of Diseases (ICD-10). Surgical procedures were grouped into broad categories according to organ 
system using ICD-9.
Results. Most of the 1,793 transfusion recipients studied were female (63.2%) and in the 
reproductive age group, i.e. 15-49 years (65.3%). The median age of the recipients was 33 years (range, 
0-93). The majority of these recipients (n=1,642; 91.6%) received a red blood cell transfusion. The 
majority of the patients were diagnosed with conditions related to pregnancy and childbirth (22.3%), 
and diseases of blood and blood-forming organs (17.7%). The median time spent in hospital was 8 
days (range, 0-214) and in-hospital mortality was 15.4%. 
Discussion. Our sample of blood transfusion recipients were fairly young and most of them 
received red blood cell transfusions. The majority of patients in the reproductive age group received 
blood transfusions for pregnancy and childbirth-related diagnoses. 
 
Keywords: blood usage, diagnosis, transfusion, International Classification of Diseases (ICD).
Introduction
Critical review and continuous evaluation of the 
use of blood and its components are essential activities 
aimed at improving transfusion practice1. These involve 
studying the demographic characteristics of blood 
transfusion recipients, the patterns of blood and blood 
component use, the clinical conditions and specialties 
requiring blood transfusion, and the risks associated 
with blood transfusion in a population. Monitoring 
blood utilisation is one way of assessing the present 
and future demands for blood and reducing unnecessary 
transfusions2. Data on blood utilisation is especially 
helpful in resource-limited settings in which there are 
always competing needs for scarce resources. Blood 
is one such scarce health resource and ensuring its 
safety and clinical effectiveness requires a great deal 
of investment, both human and financial. Information 
on blood utilisation will assist in conducting cost-
effectiveness analyses3, establishing clinical practice 
guidelines, planning efforts for recruitment of new blood 
donors and streamlining resources for the therapeutic 
benefit of patients2,4.
A number of studies on blood and blood component 
utilisation have been carried out in recent years1-3,5-12. 
Substantial variations in transfusion practices, 
arising from differences in population age structures, 
prevalences of conditions requiring transfusion, and 
levels of health care provision, have been reported4,13,14. 
However, most of these studies have been conducted in 
developed countries in which the population and disease 
burden are different from those in developing countries. 
Most developed countries have an ageing population, 
chronic non-infectious diseases and advanced surgical 
technology3,6,8,12,15, all of which may result in different 
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Profiles of transfusion recipients
patterns of blood component use when compared with 
developing countries. In contrast, the population in 
developing countries is predominantly young and blood 
utilisation patterns are likely to be different. There are 
limited published data on the characteristics of blood 
transfusion recipients in sub-Saharan Africa. The few 
studies reported that most of the limited blood supplies 
in developing countries are used for complications of 
pregnancy and childbirth, trauma and severe anaemia 
in childhood16-18. It is, therefore, imperative that blood 
utilisation studies are carried out in these settings to 
establish local use patterns in order to be able to meet 
patients' needs effectively. 
In Zimbabwe, the National Blood Service, Zimbabwe 
(NBSZ), is responsible for ensuring a safe, adequate, 
accessible and affordable supply of blood and blood 
components. Currently, the NBSZ only has complete 
information on the number and type of blood and its 
components issued to hospitals; however, the actual 
consumption data are not readily available at hospital 
level. Establishing utilisation patterns, especially 
basic parameters such as the number of patients and 
components transfused each year, will enable the blood 
service to dispatch its mandate efficiently and effectively. 
In this study, the demographic characteristics of patients 
receiving blood transfusions are described, as are the 




The study was conducted in four major hospitals, 
all located in Harare, which had the highest number of 
units of blood issued nationwide by the NBSZ in 2012; 
of the four hospital, three were public sector referral 
hospitals (Parirenyatwa Group of Hospitals, Harare 
Central Hospital, Chitungwiza Central Hospital) and 
one was a private hospital (West End Hospital). The 
four hospitals have a combined capacity of 2,490 beds, 
annual admissions of 111,794 patients, annual discharges 
of 100,774 patients, and provide most of the medical and 
surgical specialties. 
Study design 
A retrospective analysis of blood transfusion 
recipient data, covering all blood and blood components 
transfused and recorded over a 12-month period, was 
undertaken. The primary data sources were manually 
completed blood bank registers, from which a sample 
of blood transfusion recipients was selected. 
A computerised standard discharge summary for each 
patient is routinely completed, at the end of hospital 
stay, by staff in the medical records department of 
each hospital. Different systems are in place at the four 
hospitals, however they were all able to provide all the 
data fields required for this study. These registries were 
used to obtain demographic and discharge diagnoses for 
all the transfused recipients. Data collected from the 
blood banks were linked with each transfusion recipient's 
discharge summary, using the recipient's full name and 
hospital number. 
Data collection
Data were collected retrospectively from the four 
hospitals for the 12-month period from 1 January to 
31 December, 2012 and covered all blood and blood 
components recorded in the blood bank registers during 
this period. A sample size of 600 blood transfusion 
recipients per hospital, stratified by calendar month 
was targeted (i.e. 50 blood transfusion recipients were 
systematically sampled per month for each hospital). 
The monthly sampling fractions for each hospital were 
calculated by dividing the target sample size (n=50) by 
the actual total number of recipients registered each 
month. Transfusion recipient and blood component 
information was extracted from the blood bank 
registers. Data collected from the blood bank registers 
included full name, hospital number, component type, 
number of units of component, recipient blood group, 
donor blood group, date of issue of component and 
blood bank identification number for each transfusion 
recipient. Using the recipient's full name and hospital 
number, the discharge summaries were extracted from 
the computerised registries. The variables included in 
the final dataset were characteristics of the patient (age, 
sex, blood group), blood components received (type, 
quantity), primary discharge diagnoses and outcomes 
following transfusion (discharge status, duration of stay 
in hospital). 
Data evaluation
The data collected were computerised using Epi-Info 
version 719, then transferred to Microsoft Excel 2010 
(Redmond, WA, USA) and Stata 1220 for cleaning and 
statistical analysis. Transfused patients were grouped into 
broad diagnostic categories according to the 21 (I-XXI) 
chapters of the International Classification of Diseases 
(ICD-10). Surgical procedures were grouped into broad 
categories according to organ system using ICD-9. 
Statistical analysis
Categorical demographic and clinical variables (e.g. 
type of components transfused, in-hospital mortality 
rates) are summarised using frequency counts and 
percentages; all continuous measures (e.g. duration 
of hospital stay) had non-normal distributions so are 
summarised using medians and ranges. The age groups 
were categorised into: 0-14, 15-24, 25-54, 55-64 
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and over 65 years. Data were stratified according to 
sex, age, and diagnosis of the recipients. Differences 
between proportions were evaluated using Fisher's 
exact test; differences between medians were evaluated 
using the Mann-Whitney U-test (two groups) or the 
Kruskal-Wallis test (more than two groups). An a priori 
significance level of α=0.05 was set for all analyses.
Ethical considerations
Ethical approval was obtained from the Medical 
Research Council of Zimbabwe (MRCZ/B/402) and 
the Joint Parirenyatwa Hospital (Harare) and College 
of Health Sciences Research Ethics Committee 
(JREC75/12). Additional approval was obtained from 
each of the participating hospitals.
Results
 Blood and blood component distributions
A total of 53,803 units of blood were distributed 
nationally during the period under study (January-
December 2012). More than half of the blood components 
(n=28,293; 52.6%) were distributed to the four hospitals 
included in this study. Of these blood components, 
23,970 (84.7%) were distributed as red blood cells, 
3,014 (10.7%) as fresh-frozen plasma, 954 (3.4%) as 
platelets, 146 (0.5%) as paediatric packs, 90 (0.3%) as 
cryoprecipitate and 119 (0.4%) as whole blood.
Transfusion recipients and blood components
Of the 2,400 patients who were systematically 
selected for the study, discharge summaries were 
available for 1,793 patients (74.7%). Of these, 1,642 
(91.6%) received a red blood cell transfusion. The total 
number of units transfused to patients in the sample 
during the study period was 4,249, representing 15.0% 
of the blood components distributed to the four hospitals. 
Most of the transfused components were red blood cells 
(n=3,660; 86.1%) followed by fresh-frozen plasma 
(n=444; 10.4%), platelets (n=93; 2.2%), cryoprecipitate 
(n=32; 0.8%) and whole blood (n=20; 0.5%).
Demographic characteristics
The demographic characteristics and blood groups 
of the recipients are shown in Table I. Most transfusion 
recipients were female (1,126; 63.2%), of whom 851 
(75.6%) were in the reproductive age group (15-49 
years). The median age of the recipients was 33 (range, 
0-93) years. The mean age was 35 (standard deviation 
[SD]: 20) years. Approximately 10% of transfusion 
recipients were at least 65 years old, while 13.4% 
recipients were under the age of 15 years. The most 
common blood group type was O Rhesus positive (531, 
45.7%). The distribution of blood transfusion recipients 
according to sex and age is shown in Figure 1. 
Table I - The distribution of age and ABO blood groups of 
blood transfusion recipients according to sex.
Variable Recipients Males Females
n % n % n %
Age range (years)
0-14 238 13.4 148 62.2 90 37.8
15-24 250 14.1 58 23.2 192 76.8
25-54 985 55.6 282 28.6 703 71.4
55-64 115 6.5 57 49.6 58 50.4
65+ 195 10.9 107 54.9 88 45.1
Not recorded - - - - - -
Blood group
A+ 335 28.8 132 39.4 203 60.6
A– 12 1.0 3 25.0 9 75.0
AB+ 48 4.1 20 41.7 28 58.3
AB– 3 0.3 0 0 3 100
B+ 209 18.0 74 35.4 134 64.1
B– 5 0.4 3 60.0 2 40.0
O+ 531 45.7 208 39.2 323 60.8
O– 20 1.7 12 60.0 8 40.0
Not recorded 630 - - - - -
Table percentages exclude missing values.
Distribution of transfusion recipients by age, component 
transfused and primary discharge diagnosis
Figure 2 shows recipient age and sex distributions 
per blood component transfused. Of all the blood 
components transfused, the majority were transfused 
to women. Transfusion recipients in the reproductive 
age group (15-49 years) received 2,560 (69.9%) units 
of red blood cells, 372 (83.8%) units of fresh-frozen 
plasma, 62 (66.7%) units of platelets, 9 (45.0%) units 
of whole blood and 30 (93.8%) units of cryoprecipitate. 
Paediatric patients below the age of 5 years received 
155 (4.2%) units of red blood cells, 13 (2.9%) units of 
fresh-frozen plasma; 15 (16.1%) units of platelets and 
Figure 1 - The distribution of blood transfusion recipients by 
age and sex.
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Figure 2 - Age and sex distributions of blood transfusion recipients by blood component transfused.
6 (30.0%) units of whole blood. Transfusion recipients 
aged 65 years or older received the following units: red 
blood cells (n=394; 10.8%), fresh-frozen plasma (n=16; 
3.6%) and whole blood (n=2; 10.0%).
Discharge diagnoses were available for 91.6% of the 
blood transfusion recipients, with the rest of the recipients 
reported as having undergone surgical procedures. The 
distributions of blood transfusion recipients and blood 
components transfused over the broad ICD-10 discharge 
diagnosis categories are shown in Table II. The top 
five broad ICD-10 diagnostic categories accounting 
for most blood transfusion recipients were pregnancy 
and childbirth (n=363; 22.4%), diseases of blood and 
blood-forming organs (n=287; 17.5%), neoplasms 
(165; 10.1%), infectious and parasitic diseases (n=146; 
9.0%) and diseases of the digestive system (8.2%). 
Most red blood cells (n=783; 23.9%) and fresh-frozen 
plasma (205; 46.4%) were used in the pregnancy and 
childbirth diagnostic category. The category of blood and 
blood-forming organs accounted for the use of most of 
the platelets (n=24; 25.8%) and cryoprecipitate (n=28; 
87.5%), while most whole blood (n=7; 35.0%) was used 
in the injury and poisoning category. The median number 
of units transfused was two for red blood cells, platelets, 
whole blood and cryoprecipitate and four for fresh-
frozen plasma. The principal diagnoses (four character 
subcategories) associated with high usage of red blood 
cells, fresh-frozen plasma, platelets, whole blood and 
cryoprecipitate were unspecified anaemia, false labour 
(as reported, see discussion), aplastic anaemia, burns, 
and hereditary factor VIII deficiency, respectively. The 
25 most frequently encountered principal diagnoses are 
shown in Table III.
The top five broad ICD-9 procedure categories 
accounting for most blood transfusion recipients, were 
surgical procedures related to the digestive system 
(32.2%), female genital organs (26.2%), musculoskeletal 
system (17.5%), male genital organs (6.7%) and 
obstetric procedures (4.7%). Most red blood cells were 
transfused during surgical procedures on the digestive 
system (29.8%) followed by operations on female genital 
organs (26.6%), operations on the musculoskeletal 
system (18.3%), obstetric procedures (5.6%) and 
operations on male genital organs (5.4%). 
Outcomes
The mean and median duration of stay in hospital 
for transfusion recipients was 14 (SD: 18) and 8 (range, 
0-214) days, respectively. The in-hospital mortality 
for transfused patients was 15.9%, while the overall 
mortality for all the patients was 6.6%. There were 
statistically significant sex and age differences in both 
All rights reserved - For personal use only 
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time spent in hospital and survival rates at discharge. 
The duration of stay in hospital, and in-hospital mortality 
rate for the transfusion recipients are shown in Table IV. 
Discussion
This study provides information on the demographic 
characteristics of blood transfusion recipients and 
patterns of blood component use in four urban hospitals 
in Harare. Current information suggests that this is 
the first attempt at characterising blood component 
utilisation in Zimbabwe and is one of the few studies of 
this nature in sub-Saharan Africa. Of the 2,400 patients 
sampled from the hospital blood banks, discharge 
records were obtainable for 1,793 patients (74.7%). The 
discrepancy may have arisen due to erroneous entries of 
key information (patients' hospital identification numbers 
and names) by the hospital staff into the blood bank 
registers as well as the discharge summaries. It is worth 
noting that the blood bank registers at the four hospitals 
are operated manually while computerised registries are 
in place for recording patients' discharge summaries. 
It was not possible to identify patients who received a 
transfusion using the computerised registries since that 
information is not captured. While the retrieval rate is 
acceptably high, it reflects on the need for improved 
data collection and record keeping within the hospitals. 
Utilising electronic registries to capture all blood bank 
records will significantly reduce the discrepancies 
observed in this study and improve any future look-back 
activities, which are currently difficult and lack precision. 
Reviewing and extracting transfusion data from manual 
registers is labour-intensive, time-consuming and costly, 
which may explain, in part, the limited number of studies 
undertaken in sub-Saharan Africa. 
The study sample comprised a much younger cohort 
of transfusion recipients than in studies reported from 
developed countries in which the majority of transfusion 
recipients were above the age of 60 years3,6,7,11,21-25. The 
low median age in this study reflects the age structure 
of the general population in Zimbabwe, which is 
characterised by young people, with only 3.6% being 
over the age of 65 years26. The life expectancy at birth 
for Zimbabweans is currently estimated at 58 years, 
while the global population average is 70 years27. 
Table II - Distributions of blood components transfused over the broad ICD-10 discharge diagnosis categories.
Diagnostic category (ICD-10 codes) Recipients Transfused components
n % RBC % FFP % PLT % WB % CRY %
Pregnancy, childbirth and the puerperium 363 22.4 783 23.9 205 46.4 14 15.1 3 15.0 2 6.3
Blood and blood-forming organs 287 17.5 610 18.3 30 6.7 24 25.8 4 20.0 28 87.5
Neoplasms 165 10.1 378 11.4 19 4.3 18 19.4 0 0.0 2 6.3
Genitourinary system 130 7.9 297 8.9 42 9.4 1 1.1 0 0.0 0 0
Digestive system 133 8.2 276 8.4 27 6.1 5 5.4 2 10.0 0 0.0
Infectious and parasitic diseases 146 9.0 257 7.8 35 7.8 8 8.6 0 0.0 0 0.0
Injury and poisoning 93 5.7 163 4.9 15 3.4 0 0.0 7 35.0 0 0.0
Circulatory system 63 3.8 128 3.8 8 1.8 0 0.0 0 0.0 0 0.0
Respiratory system 60 3.7 105 3.2 11 2.5 0 0.0 3 15.0 0 0.0
Endocrine, nutritional and metabolic diseases 41 2.6 68 2.1 12 2.7 1 1.1 0 0.0 0 0.0
Nervous system 30 1.8 67 2.0 5 1.1 0 0.0 0 0.0 0 0.0
Symptoms, signs and abnormal clinical 
and laboratory findings 32 2.1 60 2.0 0 0.0 4 4.3 0 0.0 0 0.0
Conditions originating in the perinatal period 37 2.5 33 1.1 27 6.1 4 4.3 1 5.0 0 0.0
Skin and subcutaneous tissue 20 1.3 31 1.1 6 1.3 6 6.5 0 0.0 0 0.0
Musculoskeletal system and connective tissue 12 0.7 15 0.5 0 0.0 5 5.4 0 0.0 0 0.0
Mental and behavioural disorders 2 0.1 6 0.2 0 0.0 0 0.0 0 0.0 0 0.0
Factors influencing health status 2 0.1 5 0.2 0 0.0 0 0.0 0 0.0 0 0.0
Congenital malformations 6 0.4 3 0.1 2 0.4 3 3.2 0 0.0 0 0.0
External causes of morbidity and mortality 1 0.1 2 0.1 0 0.0 0 0.0 0 0.0 0 0.0
Ear and mastoid process 1 0.1 1 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Total percentages may not add up to 100% due to rounding. 
ICD: International Classification of Diseases; RBC: red blood cells; FFP: fresh-frozen plasma; PLT: platelets; WB: whole blood; CRY: cryoprecipitate.
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Table III - The 25 most frequent ICD-10 diagnoses.






and the puerperium 
Spontaneous abortion 53 3.3 127 3.9
Post-partum haemorrhage 54 3.3 116 3.5
Ectopic pregnancy, unspecified 29 1.8 76 2.3
False labour, unspecified 35 2.2 52 1.6
Single spontaneous delivery, unspecified 24 1.5 47 1.4
Blood 
and blood forming organs 
Anaemia, unspecified 211 13.0 455 13.8
Anaemia in other chronic diseases classified elsewhere 21 1.3 40 1.2
Aplastic anaemia, unspecified 11 0.7 35 1.1
Thrombocytopenia, unspecified 9 0.6 21 0.6
Iron deficiency anaemia, unspecified 3 0.2 10 0.3
Neoplasms Cervix uteri, unspecified 42 2.6 106 3.2
Leiomyoma of uterus, unspecified 15 0.9 36 1.1
Stomach, unspecified 11 0.7 24 0.7
Malignant neoplasm of prostate 10 0.6 19 0.6
Bladder, unspecified 7 0.4 17 0.5
Genitourinary system Unspecified kidney failure 45 2.8 95 2.9
Chronic kidney disease, unspecified 17 1.0 46 1.4
Other specified abnormal uterine and vaginal bleeding 10 0.6 26 0.8
Excessive and frequent menstruation with regular cycle 10 0.6 25 0.8
Acute renal failure, unspecified 9 0.6 16 0.5
Digestive system Gastrointestinal haemorrhage, unspecified 62 3.8 138 4.2
Other and unspecified intestinal obstruction 11 0.7 20 0.6
Peptic ulcer, site unspecified 6 0.4 17 0.5
Duodenal ulcer 4 0.2 13 0.4
Peritonitis, unspecified 6 0.4 11 0.3
ICD: International Classification of Diseases; RBC: red blood cell.
Table IV - Comparison of duration of stay in hospital and in-hospital mortality according to sex and age (n=1,793).
Variables Outcomes 
Length of stay in hospital In-hospital mortality
Recipients, n Median (range) p-value Recipients, n Rate (%) p-value 
Sex
Male 630 10 (0-145) 637 20.7
Female 1,078 7 (0-214) 0.005a 1,093 13.8 0.001c
Not recorded 85 - 63 - 
Age range (years)
0-14 231 11 (0-145) 232 19.3
15-24 238 7 (0-176) 244 10.7
25-54 949 7 (0-198) 964 14.6
55-64 118 9 (0-214) 111 17.1
65+ 172 12 (0-95) <0.001b 189 24.3 0.011c
Not recorded 85 - 53 -
a Mann-Whitney test; b Kruskal-Wallis test; c Fisher's exact test.
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Developed countries are predominantly characterised 
by ageing populations, due to the higher mean life 
expectancies. An older but comparable transfusion 
recipient population was reported in Brazil (49 years)28, 
whereas a much younger recipient population was 
described from sub-Saharan Africa18,29-31. The Zimbabwe 
national census statistics states that the male to female 
ratio in Zimbabwe is 0.95. This may, in part, explain 
why our sample cohort had more females receiving 
transfusion. Transfusion recipients in sub-Saharan 
Africa are mostly children, in malaria endemic areas, 
and women of childbearing age due to complications of 
pregnancy17,18,29,30. Receiving a blood transfusion earlier 
in life may have far-reaching implications for recipients, 
because of the inherent risks, principally transmission of 
infectious agents, and adverse reactions associated with 
blood transfusion. Exposure to these risks, for instance 
transfusion-transmitted infections, at a younger age 
may leave the recipient affected for considerably longer 
than a much older recipient because of differences in 
life expectancies at the time of exposure. For example, 
if a young transfusion recipient were to be infected by 
human immunodeficiency virus, the number of years 
lived with the disease would be much more than those 
of an older recipient. On the same note if a younger 
transfusion recipient were to die from a transfusion-
related complication, the number of life years lost would 
be much greater than the number an older recipient 
would lose. Unlike the situation in developed countries, 
most transfusions in developing countries are given 
early in life, which increases the long-term impact of 
the transfusions in recipients. The present study included 
fewer paediatric patients receiving blood transfusion, 
unlike other studies carried out in sub-Saharan Africa, 
which included many paediatric patients receiving 
blood transfusion for anaemia related to malaria18,29,30. 
This difference can be attributed to the location of the 
hospitals included in this study, as the four hospitals are 
at a high altitude and serve a population which live in a 
relatively malaria-free area. 
The distribution of ABO blood groups, among 
patients included in the study is consistent with that 
reported in the donor population in Zimbabwe32. 
Acute shortages of blood of specific groups are often 
experienced in Zimbabwe making an understanding 
of the distribution of blood groups among transfusion 
recipients important. This information is necessary for 
planning bleeds as well as distributions of blood and 
blood components; subsequently ensuring that patients 
receive blood matching their ABO blood group and 
Rhesus type. 
The majority of the transfusion recipients in the 
sample (92.6%) received red blood cell transfusions, 
which is higher percentage than that reported in studies 
from Brazil (42.0%)28 and Korea (43.3%)1, although it is 
comparable to the proportions reported from developed 
countries (56-96%)2,15,24. This is a reflection of the 
proportions in which blood and blood components are 
prepared and distributed in Zimbabwe. More than 90% 
of all collected blood is processed into components and 
about 87% of the components are distributed as red blood 
cells33. The distribution of blood components transfused 
to the recipients in this study was comparable to the 
distribution of blood components issued to the hospitals 
included in the study. Currently, the use of whole blood 
for transfusions is very low in Zimbabwe. Whole blood 
is only issued for transfusion following special requests 
by clinicians, mainly for massive haemorrhages and 
exchange transfusions. 
In this survey, women, especially in the reproductive 
age group (15-49 years), received the majority of 
the blood and blood components transfused. This is 
consistent with findings in other countries in sub-
Saharan Africa where women receive more blood 
for pregnancy-related complications, mainly related 
to intra-partum and post-partum haemorrhage18,29,30. 
Studies from developed countries found that more 
men than women receive blood transfusion3,8. This 
may be attributed to advanced health care services and 
management practices during pregnancy, which reduce 
the associated complications requiring transfusion. An 
assessment of how pregnancy is managed among women 
in Zimbabwe may assist in developing more effective 
ways of reducing pregnancy-related complications 
and subsequently the need for blood transfusion. An 
understanding of the complications occurring in these 
young women together with the associated risk factors 
may go a long way to reducing maternal mortality, 
which is currently fairly high. It might also help reduce 
exposure to blood transfusion and hence the associated 
risks.
The median number of units transfused for each 
component ranged from two for red blood cells, fresh-
frozen plasma, whole blood and cryoprecipitate to four 
for platelets. These are similar to findings from Brazil (3 
units)28, Sweden and Denmark (4 units)15, and Germany 
(1-4 units)2. In this study the median number of red 
blood cell units transfused per patient was similar for 
both males and females, while it increased from one 
unit for recipients aged less than 15 years to two to 
four units for recipients over the age of 15 years. The 
median number of red blood cell units transfused also 
varied depending on the broad diagnostic category, as 
reported in the literature2.
The top five diagnoses for which patients received 
a blood transfusion in Zimbabwe were pregnancy and 
childbirth, diseases of blood and blood-forming organs, 
neoplasms, genitourinary system disorders and diseases 
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of the digestive system. In contrast to developing 
countries, most published studies from African 
countries9,18,29,30 did not classify the diagnoses according 
the ICD-10, making direct comparisons with the findings 
in this study impossible. Only one recent study from 
Namibia used the ICD-10 classification31 and reported 
results which are relatively similar to those of our study. 
This study reported diagnoses in the infectious disease, 
pregnancy and gastrointestinal categories as accounting 
for 14.8%, 11.1% and 6.1% of red blood cell units 
issued, respectively. This underscores the importance 
of standardising methodologies for undertaking 
comparative analyses using data from related studies. 
However, malaria and pregnancy-related conditions 
were cited among top indications for blood transfusion 
in the region18,29,30. Studies from non-African countries 
found that neoplasms, injury, digestive system, and 
circulatory system as the main diagnoses associated with 
transfusion1,3,24,28. This strongly demonstrates that blood 
utilisation patterns vary significantly within regions and 
according to practices and patients' characteristics. The 
disease burdens, levels of organisation and advancement 
of health care in the different settings also contribute to 
significant differences in blood utilisation. In developed 
countries, for example, more resources are available 
and pregnant women are better cared for, from the 
onset of pregnancy, which reduces the likelihood of 
complications and requirements for blood transfusion. 
Data on the number of pregnant women requiring blood 
for transfusion is not currently available. However, 
we recognise the importance of gathering such data 
especially in the light of the high maternal mortality 
rate reported in Zimbabwe. Further work addressing 
the use of blood and blood components in obstetric care 
is warranted.
In this study, unspecified anaemia was the most 
common principal diagnosis (73.5%) under diseases of 
blood and blood-forming organs. This may be due to 
limited capacity and expertise to make specific diagnoses, 
thus overestimating diseases of blood and blood-forming 
organs, while underestimating other diagnoses. This may 
also be attributed to poor record-keeping and coding by 
clinicians and medical records staff. False (threatened) 
labour was provided as a criterion for the discharge 
diagnoses for transfusion recipients recorded in this 
study, although it is recognised that blood transfusion 
has no role in the management of this condition. This is 
an example of inaccurate, misleading and poor record-
keeping, and erroneous coding. A prospective study to 
evaluate the indications for blood transfusion will assist 
in classifying transfusion triggers and describing the 
profiles of individual recipients more precisely. This 
will also present an opportunity for assessing the use 
of and adherence to guidelines on prescribing blood 
in Zimbabwe34. "The National Blood Policy of the 
Republic of Zimbabwe"35 and "Standards for Blood 
Donation, Processing and Clinical Transfusion in 
Zimbabwe"36 were published and accepted for national 
distribution in 2010. These documents advocate the 
formation of Hospital Transfusion Committees, which 
will have the responsibility of assessing the clinical use 
of blood and blood components in hospitals. In addition, 
recommendations are made for the establishment of 
a haemovigilance programme, which will provide 
surveillance on blood donations and clinical use of 
blood. Findings from these committees and programmes 
will ensure a platform for determining adherence to 
policies, guidelines and practices in the good clinical use 
of blood, leading to effective auditing and improvements 
in transfusion practices, nationally. Training hospital 
personnel, periodic monitoring and evaluation of all 
activities related to clinical transfusion practices will 
improve the quality of record keeping, coding and most 
importantly, patients' management and care. This would 
subsequently help enhance the quantity and quality 
of reports of transfusion-related adverse events, both 
previously reported as substantially low37. 
In-hospital mortality among blood transfusion 
recipients in this study was lower than that reported 
in Brazil (24.0%)28, although it was much higher than 
that in the USA (7.6%)23. Data for patients who did not 
receive blood transfusion were not available so it was 
not feasible to assess the association between blood 
transfusion and in-hospital mortality. The duration of 
stay in hospital generally provides the level of disease 
severity of the admission diagnoses and extent of 
complications that may arise. The duration of stay 
in hospital for transfusion recipients would be more 
informative when compared with data for patients 
who had not received blood transfusions, as this would 
provide an indication of the additional burden due to 
transfusion. However, data for patients who did not 
receive blood transfusion were not available for this 
study and a comparison was only possible with data for 
transfusion recipients reported from other countries. In 
addition, the duration of stay can serve as an indicator 
of the cost burden of the admitting diagnoses beyond 
the costs incurred because of transfusion. The median 
duration of stay in hospital was lower but comparable to 
that reported for Brazil (13 days; range, 0-278)28. A study 
by Morton et al. in the USA found that the mean duration 
of stay in hospital was 9.2 days23. Male transfusion 
recipients in this study remained in hospital for more 
days and had a higher mortality rate, at discharge, than 
women recipients. This may indicate that male recipients 
had more serious medical conditions, on admission, 
which required more time to recuperate, with a reduced 
chance of survival. 
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The study has a number of potential limitations. 
First, the data were obtained from four urban hospitals, 
which may not accurately represent overall transfusion 
practices in Zimbabwe. A future prospective national 
study, which incorporates hospitals in all provinces at 
different locations, will provide a better representation of 
the patterns of blood utilisation throughout the country. 
Information on the total number of patients who received 
transfusions and the actual number of blood components 
transfused, over a specified period, was not available for 
this study. This information remains largely unknown 
because of the unavailability of electronic data systems 
and reliance on manually kept registers which are often 
not fully recorded. The number of blood components 
distributed was, therefore, used as a surrogate measure 
of consumption. These are key denominators, which are 
necessary in epidemiological studies and without them 
it is not possible, from the available data, to accurately 
extrapolate the information nationally. 
Conclusions
In this study sample, blood transfusion recipients 
were relatively young, which may result in prolonging 
of the long-term impact of blood transfusion in these 
recipients. A higher proportion of women received 
blood transfusion for conditions related to pregnancy 
and childbirth. Transfusion of red blood cells was 
predominant. Although this study presents data from a 
limited number of hospitals and a small proportion of 
patients who received blood transfusion in Zimbabwe, 
the findings provide an insight into the characteristics 
of blood transfusion recipients and form the basis for 
planning more comprehensive blood utilisation studies 
in Zimbabwe. The study also highlights the probable 
differences in utilisation patterns and practices in 
different settings. This warrants more research in our 
settings aimed at generating evidence necessary to 
inform policies and practices. 
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